“At its core, the future of integrating genetics more completely into healthcare depends on shifting how we view the impact of genetic testing—from a single interaction affecting care at one point, to multiple touch points that influence clinical care over a lifetime.”
— Am J Med Genetics, 2021
Nazareth S. To Uncover My Mother's Genetic Disorder, I Had To Lead The Way. Health Affairs. 2021 Dec; 40(12):1972-1975. PMID: 34871081.
Nazareth, Shivani MS, CGC; Hayward, Laura MS; Simmons, Emilie MS; Snir, Moran MSc, MBA; Hatchell, Kathryn E. PhD; Rojahn, Susan PhD; Slotnick, Robert Nathan MD, PhD; Nussbaum, Robert L. MD Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits, Obstetrics & Gynecology: Nov 2021 - Volume - Issue - 10.1097
Nazareth S, Hayward L, et al. May 2021. A Scalable Chatbot Platform to identify Patients who meet Cancer Genetic Testing Criteria Before Routine Medical Visits. Poster, American College of Obstetricians and Gynecologists Annual Education Meeting.
Snir M, Nazareth S, Simmons E, et al. Democratizing genomics: Leveraging software to make genetics an integral part of routine care. Am J Med Genet Part C. 2020;1–13.
Nazareth S, Nussbaum RL, Siglen E, Wicklund CA. Chatbots & artificial intelligence to scale genetic information delivery. J Genet Couns. 2020;00:1–4.
Nazareth S, Hayward L, Simmons E, Snir M, Shohat M. March 17-21, 2020. Can we really test everyone? A scalable model to identify healthy individuals at risk for hereditary cancer syndromes. Poster, American College of Medical Genetics Annual Clinical Genetics Meeting.
Nazareth, S, Simmons, E., Snir, M., Shohat, M., & Goldberg, J. (2019). Use of a chatbot to offer pre-test education for expanded carrier screening. Presented at the American College of Medical Genetics Annual Clinical Genetics Meeting. Seattle, Washington. April 2-6, 2019.
How molten is the pot? Analyzing self-reported and genetic ancestry of individuals and reproducing couples in the USA. Kasenit KE, Nazareth S, Wong K, et al. American Society of Human Genetics 2016
Ashkinadze E, Nazareth SB, et al. Expanded carrier screening: genetic counselors’ personal perspectives. Journal of Genetic Couns, Vol 25, Issue 2, March 2016.
Nazareth, S.B., Lazarin, G.A., and Goldberg J.D. (2015) Changing trends in carrier screening for genetic disease in the United States. Prenat. Diagn, 35: 931-935.
Klugman S, Scheiber-Agus N, Nazareth S, Evans EA. Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing. Genetic Testing and Molecular Biomarkers 2013;17:1-5.
Evans, EA, Haque IS, Nazareth, SB, et al. Letters to the Editor: Response to Stoll and Resta. Genetics in Medicine; 2013, Vol 15, 319-320
GA Lazarin, I Haque, S Nazareth, et al. An Empirical Estimate of Carrier Frequencies for 400+ CausalMendelian Variants: Results from an Ethnically Diverse Clinical Sample of 23,453 Individuals. Genetics in Medicine, 2013 Mar;15(3):178-86.
Saunders KH, Nazareth S, Pressman PI. BRCA in the Ashkenazi Population: Are Current Testing Guidelines Too Exclusive? Hered Cancer Clin Pract. 2011 Jun 28:9(1): 3.
Nazareth, S., Manley, S., Blazer, K. Evolving models of cancer risk genetic counseling. Perspectives Quarterly Publication. Vol 1. No. 32. Spring 2010.
Nazareth, S., H. Shane. Prenatal Genetic Counseling. In: Mark Evans, editor. Prenatal Diagnosis. [New York]: McGraw Hill, 2006. pp 71-8.
S Batra (Nazareth) et al. Awareness of Genetic Testing for Colorectal Cancer Predisposition Among Specialists in Gastroenterology. Am J Gastroenterol 97 (3), 729-33. March 2002